Sustained improvement in glucose homeostasis in lean and obese mice following chronic administration of the β3 agonist SR 58611A

British Journal of Pharmacology

Volumn 128, Issue 7, 1999, Pages 1586-1592

  Williams, Celia A ^b   Shih, Mei Fen ^a   Taberner, Peter V ^b  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b NONE

Author keywords

CBA CA mouse; Glucose tolerance; Lipogenesis; Non insulin dependent diabetes mellitus (NIDDM); Obesity; SR 58611A; 3 adrenoceptor agonist

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; GLIBENCLAMIDE; INSULIN; TRIACYLGLYCEROL; [[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG POTENCY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; LIPOGENESIS; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032733937     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702946     Document Type: Article

References (34)

1. 3-adrenergic agonist, BRL35135A, on glucose uptake in rat skeletal muscle in vivo and in vitro. J. Endocrinol., 139, 479-486.
2. 3-adrenoceptor agonist, on BAT lipogenesis in CBA/ Ca obese mice. J. Physiol., 452, 176P.
3. 3-adrenergic receptor agonists in obese mice. Am. J. Physiol., 268, E678-E684.
4. 3-adrenoceptor agonists in the treatment of obesity and diabetes. Int. J. Obesity, 20, 191-199.
5. CAWTHORNE, M.A., CARROLL, M.J., LEVY, A.L., LISTER, C.L., SENNITT, M.V., SMITH, S.A. & YOUNG, P. (1984). Effects of novel β-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin dependent diabetes. Int. J. Obesity, 8, 93-102.
6. CAWTHOKNE, M.A., SENNITI, M.V., ARCH, J.R.S. & SMITH, S.A. (1992). BRL 35135, a potent and selective atypical β-adrenoceptor agonist. Am. J. Clin. Nutr., 55, 252S-257S.
7. CHALLIS, R.A.J., LEIGHTON, M.B., WILSON, S., THURLBY, P.L. & ARCH, J.R.S. (1988). An investigation of the β-adrenoceptor that mediates metabolic responses to the novel agonist BRL 28410 in rat solcus muscle. Biochem. Pharmacol., 37, 947-950.
8. CONNACHER, A.A., BENNET, W.M., JUNG, R.T. & RENNIE, M.J. (1992). Metabolic effects of three weeks administration of the β-adrenoceptor agonist BRL 26830A. Int. J. Obesity., 16, 685-694.
9. CONNELLY, D.M. & TABERNER, P.V. (1989). Characterisation of the spontaneous diabetes obesity syndrome in mature male CBA/Ca mice. Pharmacol. Biochem. Behaviour, 34, 255-259.
10. 3-adrenergic receptor. Science, 245, 1118-1121.
11. FOSTER, D.O. & FRYDMAN, M.L. (1978). Nonshivering thermogenesis in the rat. II. Measurement of blood flow with microspheres point to brown adipose tissue as the dominant site of the calorigenesis induced by noradrenaline. Can. J. Physiol. Pharmacol., 56, 110-122.
12. 4-adrenoceptor. Br. J. Pharmacol., 122, 1244-1250.
13. GARCIA-SAINZ, J.A. & FAIN, J.N. (1982). Regulation of adipose tissue metabolism by catecholamines: roles of alpha1, alpha2 and beta-adrenoceptors. Trends Pharmacol. Sci., 3, 201-203.
14. GHORBANI, M. & HIMMS-HAGEN, J. (1997). Appearance of brown adipocytes in white adipose tissue during CL316, 243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Int. J. Obesity, 21, 465-475.
15. 3-Adrenoceptor: an update. Eur. J. Endocrinol., 132, 377-385.
16. HOLLENGA, C., HAAS, M., DEINUM, J.T. & ZAAGSMA, J. (1990). Discrepancies in lipolytic activities induced by β-adrenoceptor agonists in human and rat adipocytes. Horm. Metab. Res., 22, 17-21.
17. HOLLENGA, C. & ZAAGSMA, J. (1989). Direct evidence for the atypical nature of functional β-adrenoceptors in rat adipocytes. Br. J. Pharmacol., 98, 1420-1424.
18. 3-adrenergic receptor mRNA in man. J. Clin. Invest., 91, 344-349.
19. LIU, Y.-L., CAWTHORNE, M.A. & STOCK, M.J. (1996). Biphasic effects of the β-adrenoceptor agonist BRL 37344, on glucose utilization in rat isolated skeletal muscle. Br. J. Pharmacol., 117, 1355-1361.
20. 3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation. Br. J. Pharmacol., 114, 888-894.
21. 3-adrenoceptor in man. Br. J. Pharmacol., 110, 929-936.
22. MERCER, S.W., DENTON, R.M. & TABERNER, P.V. (1992). The development of resistance to the lipogenic effects of insulin in brown tissue and white adipose tissue of spontaneously type II diabetic male CBA/Ca mice. Int. J. Biochem., 24, 941-944.
23. MERCER, S.W. & TRAYHURN, P. (1983). Development changes in fatty acid synthesis in interscapular brown adipose tissue of lean and genetically obese (ob/ob) mice. Biochem. J., 212, 393-398.
24. MITCHELL, T.H., ELLIS, R.D.M., SMITH, S.A., ROBB, G. & CAWTHORNE, M.A. (1989). Effects of BRL 35135, a β-adrenoceptor agonist with novel selectivity, on glucose tolerance and insulin sensitivity in obese subjects. Int. J. Obesity, 13, 757-766.
25. 3-adrenoceptor-induced activation of cAMP-dependent protein kinase with activation of lipolysis in rat white adipocytes. Biochem. Pharmacol., 46, 575-581.
26. ROCHET, N., TANTI, J.F., VAN OBBERGHEN, E. & LE MARCHAND-BRUSTEL, Y. (1988). Effect of a thermogenic agent, BRL26830A, on insulin receptors in obese mice. Am. J. Physiol., 255, E101-E109.
27. SENNITT, M.V., ARCH, J.R., SIMSON, D.L., SMITH, S.A. & CAWTHORNE, M.A. (1985). Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenoceptor agonist, in mice and rats. Biochem. Pharmacol., 15, 1279-1285.f
28. 3-adrenoceptor agonists. Biochem. Pharmacol., 50, 601-608.
29. STANSBIE, D., BROWNSEY, R.W., CRETTAZ, M. & DENTON, R.M. (1976). Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochem. J., 160, 413-416.
30. UWAJIMA, T., AKITA, H., ITO, K., AISAKA, K. & TERADA, O. (1980). Formation and purification of a new enzyme glycerol oxidase and stoichiometry of the enzyme reaction. Agric. Biol. Chem., 44, 399-406.
31. 3-adrenoceptor agonist, Zeneca ZD2079, improves glucose homeostasis in insulin resistant rodents. Diabetologia, 37, A212.
32. 3-adrenoceptor agonist BRL26830A works by release of endogenous insulin. Am. J. Clin. Nutr., 55, 237S-241S.
33. 3-adrenoceptor agonist in yellow KK mice. Life Sci., 54, 491-498.
34. YOUNG, P., KING, L. & CAWTHORNE, M.A. (1985). Increased insulin binding and glucose transport in white adipocytes isolated from C57B2/6 ob/ob mice treated with the thermogenic β-adrenoceptor agonist BRL 26830. Biocem. Biophys. Res. Commun., 133, 457-461.